Zeta CEA-M Antibody. Zeta’s mouse monoclonal antibody recognizes CEA, Carcinoembryonic Antigen. Zeta’s CEA antibody clone CEA31 has a high affinity for CEA and shows no detectable reactivity to nonspecific cross-reacting antigen (NCA), biliary glycoprotein (BGP).and human polymorphonuclear leucocytes. Ab-3 shows no reaction with a variety of normal tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. The CEA antibody is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+).
Zeta Corporation is a leader in recombinant monoclonal IVD antibodies for immunohistochemistry (IHC) offering 400+ tumor and tissue specific relevant products developed by a pathologist for pathologists. Visit Precision Recombinant Antibodies – IVD Antibodies – About Zeta Corporation (zeta-corp.com) to learn more about Zeta Corporation.